Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
MGZ Medical Genetics Center | RCV002290060 | SCV002581701 | uncertain significance | Tuberous sclerosis 2 | 2022-08-01 | criteria provided, single submitter | clinical testing | |
Gene |
RCV004721038 | SCV005327936 | likely pathogenic | not provided | 2024-03-19 | criteria provided, single submitter | clinical testing | Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 27859028) |
Labcorp Genetics |
RCV002290060 | SCV005837260 | likely pathogenic | Tuberous sclerosis 2 | 2024-03-15 | criteria provided, single submitter | clinical testing | This sequence change replaces leucine, which is neutral and non-polar, with proline, which is neutral and non-polar, at codon 706 of the TSC2 protein (p.Leu706Pro). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with tuberous sclerosis complex (PMID: 27859028). In at least one individual the variant was observed to be de novo. ClinVar contains an entry for this variant (Variation ID: 1709718). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on TSC2 protein function. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. |